Insights from Jeremy Grantham (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Jeremy Grantham (

Insights into Mario Gabelli (Trades, Portfolio)'s Investment Moves in Q4 2025 Mario Gabelli (Trades,

Insights from Jeremy Grantham (Trades, Portfolio)'s Third Quarter 2025 13F Filing Jeremy Grantham (T

Sumitomo Mitsui Trust Group Inc. increased its stake in Verona Pharma PLC American Depositary Share

Verona Pharma PLC American Depositary Share (NASDAQ: VRNA - Get Free Report) is anticipated to annou

LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Veron

LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA)

Posters support Ohtuvayre ® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and

Verona Pharma (VRNA) might move higher on growing optimism about its earnings prospects, which is re

Investing in index funds is a safe way to grow your portfolio over the years. But there's a huge adv

Shield your portfolio from market swings with low-beta picks like VIPS, GDS, FUTU and VRNA, each sho

In a volatile market, low-beta picks like VIPS, ALKT, FUTU and VRNA offer investors stability with s

Does Verona Pharma PLC American Depositary Share (VRNA) have what it takes to be a top stock pick fo

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmo

Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's str

Merck agreed to buy respiratory drugmaker Verona Pharma for about $10 billion as it tries to make up

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

VRNA jumps 20% after Merck unveils buyout to add COPD drug Ohtuvayre and reduce its reliance on Keyt

Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the co

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the edu

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company anno

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

HC Wainwright & Co. cut the price target for 89bio, Inc. (NASDAQ: ETNB) from $27 to $25. HC

Companies Reporting Before The Bell • Cohen & Co (AMEX:COHN) is likely to report earnings for i

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announce

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pr

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear

Upgrades

U.S. stocks traded mixed this morning, with the Nasdaq dropping around 90 points on Tuesday.

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market t

  Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to repo

  Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly ea

  Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for it

  Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report q

  Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings